Ralph Scully | Homologous Recombination | Best Researcher Award

Dr. Ralph Scully | Homologous Recombination | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Google Scholar

RALPH SCULLY: PIONEER IN GENOMIC STABILITY AND DNA REPAIR 🧬

Dr. Ralph Scully is a globally recognized leader in cancer biology, genomic stability, and DNA repair mechanisms. His illustrious academic career spans decades, marked by groundbreaking research and influential leadership in the biomedical sciences.

EARLY ACADEMIC PURSUITS 🎓

Dr. Scully began his academic journey with a B.A. (Hons) in Medical Sciences and English from the University of Cambridge in 1983, followed by an M.B., B.S. in Clinical Sciences from University College London in 1986. He later earned an M.A. in Medical Sciences and English in 1990 and culminated his academic studies with a Ph.D. in Immunology under the mentorship of Herman Waldmann, F.R.S., at Cambridge in 1994. This interdisciplinary foundation laid the groundwork for his innovative approach to medical research.

PROFESSIONAL ENDEAVORS 🏥

Dr. Scully’s professional trajectory showcases his dedication to both clinical and academic excellence:

  • Postdoctoral Training (1994-1997): Focused on neoplastic disease mechanisms at the Dana-Farber Cancer Institute under Dr. David M. Livingston.
  • Harvard Medical School Faculty: Starting as an Instructor in 1997, he progressed through the ranks to become a Professor of Medicine in 2017. He has also served as faculty for the Ph.D. Program in Biological and Biomedical Sciences.
  • Administrative Leadership: Co-Director of the Program in DNA Repair and Genomic Instability at Beth Israel Deaconess Medical Center since 2018.

CONTRIBUTIONS AND RESEARCH FOCUS ON HOMOLOGOUS RECOMBINATION🔬

Dr. Scully's research explores the molecular mechanisms of DNA repair, genomic instability, and cancer biology, particularly in relation to BRCA genes. His work has illuminated pathways critical to understanding cancer development and therapy resistance. Highlights include:

  • Leading efforts in understanding genomic rearrangements and mutational signatures in cancer.
  • Driving advancements in genome editing technologies and their implications for cancer prevention and treatment.
  • Collaborative projects on BRCA-linked cancer prevention, including international coalitions.

IMPACT AND INFLUENCE 🌍

Dr. Scully has profoundly influenced the field through:

  • Organizing major scientific conferences such as the Keystone Symposium on Genomic Instability and DNA Repair (2023) and the FASEB Conference on Genetic Recombination (2026, 2028).
  • Serving as a chair and advisory member for numerous academic committees, fostering collaborations across global institutions.
  • His mentorship of emerging scientists, equipping the next generation with critical insights into genomic medicine.

ACADEMIC CITATIONS AND RECOGNITION 📚

Dr. Scully's publications are extensively cited, reflecting the high impact of his research in genomics and cancer biology. As a thought leader, he has contributed to the editorial boards and review committees of prestigious journals and funding agencies, ensuring the dissemination of transformative research.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Dr. Scully’s ongoing commitment to tackling genomic instability has positioned him as a pioneer whose work continues to inform cancer prevention and treatment strategies. His leadership in upcoming conferences and collaborative projects signifies a lasting legacy in the biomedical field.

OTHER NOTABLE ACHIEVEMENTS 🏅

  • Professional Societies: Member of esteemed organizations such as the American Association for Cancer Research and the Association of American Physicians.
  • Consultancy Roles: Provided expert guidance to biotech companies like Editas, Cyteir, and MoMa Therapeutics.
  • Grant Reviews and Committees: Regularly contributes to panels for the NIH, ACS, and Charles A. King Trust Fellowship Program.

NOTABLE PUBLICATIONS 📑

"One-ended and two-ended breaks at nickase-broken replication forks

  • Authors: Scully, R. , Walter, J.C. , Nussenzweig, A.
  • Journal: DNA Repair
  • Year: 2024

"Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells

  • Authors: Elango, R. , Panday, A. , Willis, N.A. , Scully, R.
  • Journal: STAR Protocols
  • Year: 2022

"A modified CUT&RUN-seq technique for qPCR analysis of chromatin-protein interactions

  • Authors: Panday, A. , Elango, R. , Willis, N.A. , Scully, R.
  • Journal: STAR Protocols
  • Year: 2022

"The structure-specific endonuclease complex SLX4–XPF regulates Tus–Ter-induced homologous recombination

  • Authors: Elango, R. , Panday, A. , Lach, F.P. , Smogorzewska, A. , Scully, R.
  • Journal: Nature Structural and Molecular Biology
  • Year: 2022

"Recombination and restart at blocked replication forks

  • Authors: Scully, R. , Elango, R. , Panday, A. , Willis, N.A.
  • Journal: Current Opinion in Genetics and Development
  • Year: 2021

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024